Health systems rushed enthusiastically into expensive medical technologies such as proton beam centers. But now that employers, insurers and government seem determined to curb growth in healthcare spending and to combat overcharges and wasteful procedures, such bets are less of a sure thing.
The average cost of recruiting a trial subject via the targeted Facebook ads was $35, 96 percent less than the $800-per-person average through other means for the Michael J. Fox Foundation study.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
New technology created by Cellular Dynamics International has licensed its development to Indiana University, which creates new human blood vessels for those with peripheral arterial disease.
While it was hard to engage patients in large numbers, those who did participate saw marked gains in their medication adherence, though clinical measures did not really improve.
Lawyers for the federal government want to get their hands on the medical records of disgraced cycling champion and cancer survivor Lance Armstrong in order to see if Armstrong's physicians knew he was using performance-enhancing drugs as early as 1996.
Indiana researchers are diving deep to understand the costs and healthcare outcomes of precision medicine.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
An Indiana University spinout attracted investors from Johnson & Johnson Development Corp. and BioCrossroads with novel drugs to treat, and even potentially cure, patients with hepatitis B. Assembly Pharmaceuticals received an undisclosed amount for this seed round. This funding will finance the preclinical proof of concept and help the company establish its bio labs in San Francisco, […]
Visual art has helped doctors and surgeons-to-be learn about anatomy, procedure and disease for centuries. “Visualizing Disease,” an exhibit at Indiana University’s Lilly Library, showcases art from as early as the 1500s that was made with the intent of growing human knowledge in medicine. “Typically, artists have been interested in the human body and the […]
Biocrossroads, which provides money and support to Indiana’s life sciences industry, announced the seven finalists who stand to gain startup funding in its annual New Venture Competition. Six have biotech or healthcare in their sights. On Oct. 21, five of these companies will compete for $25,000 and access to the Indiana Seed II Fund‘s staff […]
Roche and Eli Lilly are among major life science players in Indiana putting resources behind a public-private research institute that would discover and develop new health innovations. Industry leaders from the drugmakers, along with Biomet, Cook Medical, Dow AgroSciences and Indiana University Health have defined a set of common scientific interests that will be the […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
It’s not just the masterminds at IBM that can create machines designed to think like doctors. A pair of researchers at Indiana University say they have devised an artificial intelligence framework that may outperform physicians in making cost-effective clinical decisions that result in good outcomes. “The Markov Decision Processes and Dynamic Decision Networks enable the […]
A startup applying its novel technology platform to treatments for eye diseases and some of the most deadly cancers has just locked up $2 million in private equity investments, according to a recent U.S. Securities and Exchange Commission filing. ApeX Therapeutics, co-founded by IU cancer researcher Dr. Mark Kelley, has developed a platform technology that […]
University research and pharmaceutical employees need to replace distrust and disdain with collaboration if Indiana is to preserve and expand its place in the top tier of life sciences communities. Eli Lilly CEO Dr. John Lechleiter stressed culture change in a presentation Tuesday in Indianapolis.
What do Purdue University, Indiana University and the University of Notre Dame have in common — besides that they’re Indiana teams playing the 2012 NCAA tournament? They’re all great schools for medical innovation and have produced noteworthy discoveries the led to successful licensing agreements and life science startup companies. Not to take the focus away […]
Doctors may be able to identify signs and symptoms of kidney infections faster than traditional lab tests if a new monitoring tool from FAST BioMedical does well in clinical trials. FAST BioMedical has developed a small and durable bedside device that detects acute kidney failure by monitoring the presence of in vivo markers that are […]